Business
Spectral announces the appointment of Mr. Guillermo Herrera to its Board of Directors
Spectral announces the appointment of Mr. Guillermo Herrera to its Board of Directors.
About this update from Spectral Medical Inc
[{"type":"text","content":"\n\n\n\n\nTORONTO, Sept. 22 /CNW/ - Spectral Diagnostics Inc. (\"Spectral\") today\nannounced the addition of Mr. Guillermo Herrera to its Board of Directors. Mr\nHerrera joins Mr. R. Ian Lennox (Chairman), Mr. Edward McCormack, Dr. Henry\nFreisen, Mr. Gordon Peterson, and Dr. Paul Walker on the new Board that was\nelected at the Company's annual general meeting on September 14, 2006.\n\n\"We are very pleased that Mr. Guillermo Herrera has joined our Board,\"\nstated Dr. Paul Walker, President and CEO of Spectral. \"Mr. Herrera is a\nseasoned, very knowledgeable executive in the global health care sector, with\nbroad operational and commercial experience, including specialty and hospital\npharmaceutical products. Mr. Herrera spent 24 years at Abbott Laboratories,\nmost recently serving as Senior Vice President, International Operations and\nPresident of Abbott International. In 2004, Mr. Herrera joined Rosetta\nPartners LLC as the Partner and Principal in charge of the private equity\ndivision. He currently serves as President and CEO of NeoPharm, Inc. (NASDAQ:\nNEOL),\" added Dr. Walker.\n\n\"I am delighted to join the Board of Directors of Spectral. I see a\nsignificant opportunity to expand the leadership position Spectral has with\nits unique products, particularly in the area of Sepsis and infectious\ndiseases,\" stated Mr. Herrera.\n\nSpectral is a developer of innovative technologies for comprehensive\ndisease management. Spectral provides accurate and timely information to\nclinicians enabling the early initiation of appropriate and targeted therapy.\nCurrent products include Spectral's Rapid 1(TM) West Nile Virus assay and its\nFDA approved rapid diagnostic for sepsis, the EAA(TM), as well as a range of\nother biological reagents. Spectral's common shares are listed on The Toronto\nStock Exchange: SDI.\n\nInformation in this news release that is not current or historically\nfactual information may constitute forward-looking information within the\nmeaning of securities laws. Implicit in this information, the future outlook\nof Spectral and anticipated events or results is assumptions based on beliefs\nof Spectral's senior management as well as information currently available to\nit. While these assumptions were considered reasonable by Spectral at the time\nof preparation, they may prove to be incorrect. Readers are cau...